Blood test results showed elevated levels of myeloperoxidase (MPO)-ANCA and proteinase 3 (PR3)-ANCA, which were negative before the patient had received treatment for Graves’ disease, suggesting the presence of propylthiouracil-induced AAV. The gene discussed is PRTN3; the disease is Graves disease.